Clinical Trial Update: Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating bevacizumab, erlotinib, and 5-fluorouracil with external beam radiation therapy in locally advanced rectal cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Rectum
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Rectal Cancer, Adenocarcinoma of the Rectum | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-10